Prosecution Insights
Last updated: April 19, 2026

Tanvex Biopharma Usa Inc.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
1
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17625655 TEMPERATURE-CONTROLLED PURIFICATION OF GRANULOCYTE-COLONY STIMULATING FACTOR GERMAIN, ADAM ADRIEN 1777 Final Rejection Jan 07, 2022
17605179 PROCESS FOR PREPARING GRANULOCYTE-COLONY STIMULATING FACTOR BREEN, KIMBERLY CATHERINE 1657 Non-Final OA Oct 20, 2021

Managing Tanvex Biopharma Usa Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month